IC
KNSA icon

IEQ Capital’s Kiniksa Pharmaceuticals KNSA Stock Holding History

IEQ Capital’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Sell
29,746
-13,204
-31% -$685K 0.01% 819
2026
Q1 		$2.07M Sell
42,950
-4,891
-10% -$217K 0.01% 756
2025
Q4 		$1.97M Buy
47,841
+1,854
+4% +$74.4K 0.01% 799
2025
Q3 		$1.79M Sell
45,987
-929
-2% -$30.2K 0.01% 802
2025
Q2 		$1.3M Buy
46,916
+3,291
+8% +$83.8K 0.01% 775
2025
Q1 		$969K Buy
+43,625
New +$898K 0.01% 771

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

IEQ Capital's KNSA Position: Q2 2026 in Review

IEQ Capital reduced its Kiniksa Pharmaceuticals (KNSA) stake by 31% in Q2 2026, selling an estimated $685K and leaving 29,746 shares worth $1.9M. The position accounts for 0.01% of the portfolio, ranked #819.

IEQ Capital first reported a position in KNSA in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.07M in Q1 2026. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • IEQ Capital held 29,746 shares of Kiniksa Pharmaceuticals worth $1.9M as of Q2 2026.
  • IEQ Capital sold 13,204 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $685K.
  • Kiniksa Pharmaceuticals made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #819 holding.
  • IEQ Capital first reported a position in Kiniksa Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • IEQ Capital's Kiniksa Pharmaceuticals position peaked at $2.07M in Q1 2026.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.